Barr Confirms Patent Challenge of Amrix Extended-Release Capsules, 15mg & 30mg
Barr Pharmaceuticals, Inc. today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patent listed by Anesta in connection with its Amrix extended-release capsules, 15mg ...